1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-12-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 13048535 2024-12-01 2025-11-30 13048535 2025-11-30 13048535 2024-11-30 13048535 2023-12-01 2024-11-30 13048535 2024-11-30 13048535 2023-11-30 13048535 bus:Director1 2024-12-01 2025-11-30 13048535 core:WithinOneYear 2025-11-30 13048535 core:WithinOneYear 2024-11-30 13048535 bus:Director1 2024-11-30 13048535 bus:Director1 2025-11-30 13048535 bus:Director1 2023-11-30 13048535 bus:Director1 2024-11-30 13048535 bus:Director1 2023-12-01 2024-11-30 13048535 bus:Micro-entities 2024-12-01 2025-11-30 13048535 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 13048535 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 13048535 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 13048535 bus:FullAccounts 2024-12-01 2025-11-30
COMPANY REGISTRATION NUMBER: 13048535
GOOD GP LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 November 2025
GOOD GP LTD
FINANCIAL STATEMENTS
YEAR ENDED 30th NOVEMBER 2025
Contents
Pages
Statement of financial position and the notes to the financial statements
1 to 2
GOOD GP LTD
STATEMENT OF FINANCIAL POSITION
30 November 2025
2025
2024
£
£
£
£
Fixed assets
214
957
----
----
Current assets
12,016
14,070
Creditors: amounts falling due within one year
10,627
13,697
--------
--------
Net current assets
1,389
373
-------
-------
Total assets less current liabilities
1,603
1,330
Provisions for liabilities
41
218
Accruals and deferred income
700
684
-------
-------
862
428
-------
-------
Capital and reserves
862
428
----
----
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
2. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2025
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Dr R.J. Ignaczuk
( 9,411)
( 172)
9,411
( 172)
-------
----
-------
----
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Dr R.J. Ignaczuk
4,125
( 9,411)
( 4,125)
( 9,411)
-------
-------
-------
-------
For the year ending 30th November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 25 August 2026 , and are signed on behalf of the board by:
Dr R.J. Ignaczuk
Director
Company registration number: 13048535
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 12 Lake View, Houghton Regis, Dunstable, LU5 5GJ.